Original Research
Accepted on 04 Mar 2025
Efficacy and safety of PD-1/PD-L1 inhibitors combined with tyrosine kinase inhibitors as first-line treatment for hepatocellular carcinoma: A meta-analysis and trial sequential analysis of randomized controlled trials
in Pharmacology of Anti-Cancer Drugs